Franco Locatelli
0000-0002-7976-3654
Publication & Citation Trends
Publications
0 total
Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.
Cited by 0
Semantic Scholar
Comparable outcomes of HSCT up-front and after failure of IST in pediatric aplastic anemia in recent years
Cited by 0
Semantic Scholar
Anti-CD19 CAR T cells for pediatric patients with treatment-refractory autoimmune diseases.
Cited by 3
Semantic Scholar
Management of transfusion-dependent β-thalassaemia in the era of novel therapies: a prioritisation-based matrix for settings with limited resources.
Cited by 1
Semantic Scholar
Advancing precision therapy in pediatric acute myeloid leukemia through PDX models and mitochondrial targeting
Cited by 0
Semantic Scholar
Second Allogeneic Hematopoietic Cell Transplantation After Graft Failure Is an Effective Curative Option in Children With Hemoglobinopathies
Cited by 0
Semantic Scholar
clinTALL: machine learning-driven multimodal subtype classification and treatment outcome prediction in pediatric T-ALL
Cited by 0
Semantic Scholar
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial
Cited by 10
Semantic Scholar
Sustained Benefit of Blinatumomab in Infants With KMT2A-Rearranged ALL: Long-Term Outcomes, Toxicity, and Pharmacokinetics
Cited by 0
Semantic Scholar
More Options for Gene Editing in Hemoglobinopathies
Cited by 0
Semantic Scholar
Research Topics
Hematopoietic Stem Cell Transplantation
(518)
Acute Lymphoblastic Leukemia research
(506)
Acute Myeloid Leukemia Research
(404)
Immune Cell Function and Interaction
(294)
CAR-T cell therapy research
(275)
Affiliations
Università Cattolica del Sacro Cuore
Goethe University Frankfurt
University of Rome Tor Vergata
University of Verona
Brigham and Women's Hospital